XTX Topco Ltd Acquires Shares of 69,988 Teladoc Health, Inc. (NYSE:TDOC)

XTX Topco Ltd acquired a new stake in Teladoc Health, Inc. (NYSE:TDOC - Free Report) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 69,988 shares of the health services provider's stock, valued at approximately $557,000.

Several other large investors have also recently bought and sold shares of TDOC. Point72 Asset Management L.P. lifted its stake in shares of Teladoc Health by 33.6% in the 4th quarter. Point72 Asset Management L.P. now owns 11,179,863 shares of the health services provider's stock valued at $101,625,000 after purchasing an additional 2,813,568 shares in the last quarter. Maple Rock Capital Partners Inc. increased its holdings in Teladoc Health by 189.5% in the 4th quarter. Maple Rock Capital Partners Inc. now owns 3,561,000 shares of the health services provider's stock valued at $32,369,000 after purchasing an additional 2,331,000 shares in the last quarter. Two Sigma Investments LP acquired a new stake in Teladoc Health in the 4th quarter valued at $18,348,000. Two Sigma Advisers LP increased its holdings in Teladoc Health by 213.0% in the 4th quarter. Two Sigma Advisers LP now owns 2,258,711 shares of the health services provider's stock valued at $20,532,000 after purchasing an additional 1,537,094 shares in the last quarter. Finally, Renaissance Technologies LLC increased its holdings in Teladoc Health by 15.5% in the 4th quarter. Renaissance Technologies LLC now owns 5,674,542 shares of the health services provider's stock valued at $51,582,000 after purchasing an additional 763,265 shares in the last quarter. Hedge funds and other institutional investors own 76.82% of the company's stock.

Insider Buying and Selling

In related news, insider Carlos Nueno sold 3,958 shares of the firm's stock in a transaction on Monday, June 2nd. The stock was sold at an average price of $6.86, for a total transaction of $27,151.88. Following the sale, the insider owned 17,645 shares of the company's stock, valued at approximately $121,044.70. This trade represents a 18.32% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Fernando M. Rodrigues sold 4,174 shares of Teladoc Health stock in a transaction dated Tuesday, June 3rd. The shares were sold at an average price of $6.91, for a total value of $28,842.34. The disclosure for this sale can be found here. In the last quarter, insiders have sold 18,656 shares of company stock valued at $128,189. 0.58% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

TDOC has been the topic of several analyst reports. Jefferies Financial Group dropped their target price on Teladoc Health from $10.00 to $8.00 and set a "hold" rating on the stock in a report on Monday, April 21st. Wells Fargo & Company dropped their target price on Teladoc Health from $10.00 to $8.00 and set an "equal weight" rating on the stock in a report on Thursday, May 8th. The Goldman Sachs Group reduced their price objective on Teladoc Health from $13.00 to $10.00 and set a "buy" rating for the company in a research report on Thursday, May 1st. Needham & Company LLC restated a "hold" rating on shares of Teladoc Health in a research report on Thursday, May 1st. Finally, Citigroup reduced their price objective on Teladoc Health from $11.00 to $8.75 and set a "neutral" rating for the company in a research report on Friday, April 25th. Twelve analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $9.76.

Teladoc Health Price Performance

Shares of Teladoc Health stock traded up $0.02 during midday trading on Friday, hitting $6.97. 6,007,119 shares of the company were exchanged, compared to its average volume of 7,890,825. The company has a debt-to-equity ratio of 0.70, a current ratio of 2.67 and a quick ratio of 2.58. The firm has a market cap of $1.23 billion, a P/E ratio of -5.86 and a beta of 1.76. Teladoc Health, Inc. has a 52 week low of $6.35 and a 52 week high of $15.21. The firm has a 50 day simple moving average of $7.71 and a 200-day simple moving average of $8.42.

Teladoc Health (NYSE:TDOC - Get Free Report) last released its quarterly earnings results on Tuesday, July 29th. The health services provider reported ($0.19) EPS for the quarter, topping analysts' consensus estimates of ($0.27) by $0.08. The business had revenue of $631.90 million for the quarter, compared to analyst estimates of $621.91 million. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.16%. Teladoc Health's revenue for the quarter was down 1.6% on a year-over-year basis. During the same period in the prior year, the company earned ($0.38) EPS. Research analysts forecast that Teladoc Health, Inc. will post -1.16 earnings per share for the current year.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.